• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Combined High Serum Ferritin and Low Iron Saturation in Hemodialysis Patients: The Role of Inflammat

Combined High Serum Ferritin and Low Iron Saturation in Hemodialysis Patients: The Role of Inflammat

来源 :2013年中国肾性贫血治疗专家共识研讨会 | 被引量 : 0次 | 上传用户：dypplay
【摘 要】
：
Background: Serum ferritin, frequently used as a marker of iron status in individuals with chronic kidney disease, is also an inflammatory marker.The concurrent combination of high serum ferritin and
【作 者】
：
Mehdi Rambod Csaba P.Kovesdy Kamyar Kalantar-Zadeh 
【机 构】
：
Harold Simmons Center for Kidney Disease Research and Epidemiology, Los Angeles Biomedical Research
【出 处】
：
2013年中国肾性贫血治疗专家共识研讨会
【发表日期】
：
2012年12期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background: Serum ferritin, frequently used as a marker of iron status in individuals with chronic kidney disease, is also an inflammatory marker.The concurrent combination of high serum ferritin and low iron saturation ratio (ISAT) usually poses a diagnostic dilemma.We hypothesized that serum ferritin ≥500 ng/ml, especially in the seemingly paradoxical presence of ISAT level ＜25％, is more strongly associated with inflammation than with iron in maintenance hemodialysis (MHD) patients.
其他文献
Can the Response to Iron Therapy Be Predicted in Anemic Nondialysis Patients with Chronic Kidney Dis
Background and objectives: Anemia is iron responsive in 30 to 50% of nondialysis patients with chronic kidney disease (CKD), but the utility of bone marrow iron stores and peripheral iron indices to p
会议
Low hemoglobin density potential marker of iron availability
Introduction: Low hemoglobin density (LHD%) is a new parameter provided by Beckman-Coulter derived from the mean cell hemoglobin concentration, using the mathematical sigmoid transformation LHD% =100
会议
Functional iron deficiencyhypochromic red blood cellslow hemoglobin densityer
A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatme
Background.Iron deficiency is a common cause of anaemia and hyporesponsiveness to erythropoiesis-stimulating agents (ESAs) in non-dialysis-dependent chronic kidney disease (ND-CKD) patients.Current in
会议
anaemiaCKDferritinintravenous irontransferrin saturation
Ferric Gluconate Is Highly Efficacious in Anemic Hemodialysis Patients with High Serum Ferritin and
Few data exist to guide treatment of anemic hemodialysis patients with high ferritin and low transferrin saturation (TSAT).The Dialysis Patients Response to Ⅳ Iron with Elevated Ferritin (DRIVE) trial
会议
A randomized, controlled trial comparing Ⅳ iron sucrose to oral iron in anemic patients with nondial
A randomized, controlled trial comparing Ⅳ iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD.Background.Although iron deficiency frequently complicates anemia in patients wit
会议
CKDanemiaironiron deficiencyiron sucrose
Intravenous Versus Oral Iron Supplementation for the Treatment of Anemia in CKD: Systematic Review a
Background: Iron supplementation is essential for the treatment of patients with anemia of chronic kidney disease (CKD).It is not clear which is the best method of iron administration.Study Design: Sy
会议
Anemiaironchronic kidney diseasehemodialysishemoglobinmeta-analysis
A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplement
Background.Concomitant iron supplementation is required in the great majority of erythropoietin (Epo)-treated patients with end-stage renal failure.Intravenous (i.v.) iron supplementation has been dem
会议
erythropoietinferritinhaemoglobinsiron economicsperitoneal dialysisprospect
Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin
Background.Haemodialysis patients need sustained treatment with intravenous iron because iron deficiency limits the efficacy of recombinant human epoetin therapy in these patients.However, the optimal
会议
anaemiaepoetinshaemodialysisiron sucroseoutcome
Optimization of Epoetin Therapy with Intravenous Iron Therapy in Hemodialysis Patients
Iron deficiency limits the efficacy of recombinant human erythropoietin (rhEPO) therapy in end-stage renal disease (ESRD)patients.Functional iron deficiency occurs with serum ferritin >500 ng/ml and/o
会议
Ferumoxytol for Treating Iron Deficiency Anemia in CKD
Iron deficiency is an important cause of anemia in patients with chronic kidney disease (CKD), but intravenous iron is infrequently used among patients who are not on dialysis.Ferumoxytol is a novel i
会议